Sex-specific effects of maternal metformin intervention during glucose-intolerant obese pregnancy on body composition and metabolic health in aged mouse offspring

Author(s)

Schoonejans, Josca M. ; Blackmore, Heather L. ; Ashmore, Thomas J. ; Pantaleao, Lucas C. ; Pisani, Luciana Pellegrini ; Dearden, Laura ; Tadross, John A. ; Aiken, Catherine E. ; Fernandez-Twinn, Denise S. ; Ozanne, Susan E.

• Document type: Journal article
• Source: Diabetologia; v. 65, n. 12, p. 14-pg., 2022-09-16.

Abstract

Aims/hypothesis Metformin is increasingly used to treat gestational diabetes (GDM) and pregnancies complicated by pregestational type 2 diabetes or polycystic ovary syndrome but data regarding long-term offspring outcome are lacking in both human studies and animal models. Using a mouse model, this study investigated the effects of maternal metformin intervention during obese glucose-intolerant pregnancy on adiposity, hepatic steatosis and markers of metabolic health of male and female offspring up to the age of 12 months. Methods C57BL/6J female mice were weaned onto either a control diet (Con) or, to induce pre-conception obesity, an obesogenic diet (Ob). The respective diets were maintained throughout pregnancy and lactation. These obese dams were then randomised to the untreated group or to receive 300 mg/kg oral metformin hydrochloride treatment (Ob-Met) daily during pregnancy. In male and female offspring, body weights and body composition were measured from 1 month until 12 months of age, when serum and tissues were collected for investigation of adipocyte cellularity (histology), adipose tissue inflammation (histology and quantitative RT PCR), and hepatic steatosis and fibrosis (histochemistry and modified Folch assay). Results At 12 months of age, male Ob and Ob-Met offspring showed increased adiposity, adipocyte hypertrophy, elevated expression of proinflammatory genes, hyperleptinaemia and hepatic lipid accumulation compared with Con offspring. Male Ob-Met offspring failed to show hyperplasia between 8 weeks and 12 months, indicative of restricted adipose tissue expansion, resulting in increased immune cell infiltration and ectopic lipid deposition. Female Ob offspring were relatively protected from these phenotypes but Ob-Met female offspring showed increased adiposity, adipose tissue inflammation. hepatic lipid accumulation, hyperl cptinaemia and hyperinsulinaemia compared with Con female offspring. Conclusions/interpretation Maternal metformin treatment of obese dams increased offspring metabolic risk factors in a sex- and age-dependent manner. These observations highlight the importance of following up offspring of both sexes beyond early adulthood after interventions during pregnancy. Our findings illustrate the complexity of balancing short-term benefits to mother and child vs any potential long-term metabolic effects on the offspring when prescribing therapeutic agents that cross the placenta. (AU)

• FAPESP's process: 19/22635-4 - The effects of maternal obesity on offspring health focussed on the role of adipose tissue miRNA
• Grantee: Luciana Pellegrini Pisani
• Support Opportunities: Scholarships abroad - Research